NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-043-2010-0-PCT-02 Infectious Hepatitis C Viruses of Genotype 3A and 4A and Uses Thereof PCT PCT PCT/DK2010/050236 Expired
NCI E-171-2010-1-EP-04 HIV-l ANTIBODIES EP National Stage 10817555.5 Abandoned
NCI E-171-2010-1-CA-03 HIV-l ANTIBODIES CA National Stage 2774446 Abandoned
NCI E-171-2010-1-AU-02 HIV-l ANTIBODIES AU National Stage 2010296058 Abandoned
NHLBI E-108-2010-0-US-01 Methods and Devices For Transcatheter Cerclage Annuloplasty US 61/383,061 Abandoned
NHLBI E-288-2010-0-US-01 Closure Device For Cardiac Surgery US 61/382,931 Abandoned
NCI E-162-2009-0-CA-05 Pharmaceutical Compositions which Inhibit FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same CA National Stage 2774327 Abandoned
NCI E-205-2009-0-AU-03 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer AU National Stage 2010301042 Abandoned
NCI E-162-2009-0-AU-04 Pharmaceutical Compositions which Inhibit Of FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same AU National Stage 2010295806 Abandoned
NCI E-205-2009-0-PCT-02 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer PCT PCT PCT/US2010/048701 Expired
NCI E-162-2009-0-PCT-03 Pharmaceutical Compositions which Inhibit Of FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same PCT PCT PCT/US2010/048705 Expired
NCI E-205-2009-0-EP-06 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer EP National Stage 10754393.6 Abandoned
NCI E-162-2009-0-EP-06 Pharmaceutical Compositions which Inhibit FKBP52-Mediated Regulation Of Androgen Receptor Function And Methods of Using Same EP National Stage 10760834.1 Abandoned
NCI E-205-2009-0-CA-04 Anti-Vascular Endothelial Growth Factor Receptor-2 Chimeric Antigen Receptors And Use Of Same For The Treatment Of Cancer CA National Stage 2776143 Abandoned
NCI E-296-2009-0-PCT-02 Cellular Noncoding miR-1293 and Mir-608 Are Inhibitors, Respectively, for the Expression of KSHV cIL6 and Human IL6 PCT PCT PCT/US2010/048651 Abandoned
NIAID E-232-2004-2-US-10 Compositions And Methods For Generating An Immune Response US CON 12/880,905 Abandoned
NCI E-269-2009-0-AU-03 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity AU National Stage 2010292069 Issued
NCI E-269-2009-0-JP-08 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity JP National Stage 2012-528940 Issued
NCI E-269-2009-0-ES-12 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity ES EP 10755283.8 Issued
NCI E-269-2009-0-GB-14 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity GB EP 10755283.8 Issued
NCI E-269-2009-0-IT-15 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity IT EP 10755283.8 Issued
NCI E-269-2009-0-DE-11 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity DE EP 10755283.8 Issued
NCI E-269-2009-0-FR-13 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity FR EP 10755283.8 Issued
NCI E-269-2009-0-EP-06 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity EP National Stage 10755283.8 Issued
NCI E-269-2009-0-CN-05 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity CN National Stage 201080049559.3 Abandoned
NIDCR E-194-2010-0-US-01 Epidermal Growth Factor Receptor (EGFR) And Methods Of Use In Adenoviral-Associated Virus Type 6 (AAV6) Transduction US ORD 12/879,142 8808684 Issued PDF
NCI E-269-2009-0-PCT-02 Improved Pseudomonas Exotoxin A With Reduced Immunogenicity PCT PCT PCT/US2010/048504 Expired
NCI E-079-2009-1-PCT-02 Assays For Soluble IL-15 Receptor Alpha PCT PCT PCT/US2010/048451 Expired
NIAID E-244-2009-0-PCT-02 Specific Labeling Reagents For The Detection Of Mycobacterial Infections PCT PCT PCT/GB2010/051519 Expired
NIAID E-244-2009-0-EP-04 DETECTION OF MYCOBACTERIA EP National Stage 10761063.6 Abandoned
NCI E-188-2010-0-US-01 Anti-Human Folate Receptor Beta Antibodies and Methods of Use US 61/381,340 Abandoned
NHLBI E-243-2009-0-PCT-02 METHOD FOR THE TREATMENT OF PULMONARY DISEASE AND METHOD OF PRODUCING PROTEINS OF USE THEREIN PCT PCT PCT/US2010/048068 Expired
NIDA E-264-2007-0-NZ-06 METHODS AND COMPOSITIONS FOR PREDICTING SUCCESS IN ADDICTIVE SUBSTANCE CESSATION AND FOR PREDICTING A RISK OF ADDICTION NZ National Stage 587854 Abandoned
NIDCR E-233-2007-0-US-03 Tendon Stem Cells US National Stage 12/663,663 8545888 Abandoned PDF
NIA E-172-2009-0-EP-05 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells EP National Stage 10814480.9 Issued
NIA E-172-2009-0-FR-10 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells FR EP 10814480.9 Issued
NIA E-172-2009-0-DE-09 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells DE EP 10814480.9 Issued
NIA E-172-2009-0-GB-11 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells GB EP 10814480.9 Issued
NIA E-172-2009-0-JP-06 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells JP National Stage 2012-528039 Issued
NIA E-172-2009-0-AU-03 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cellsx2009/0-AU AU National Stage 2010289423 Issued
NIAMS E-210-2009-0-PCT-02 Disabling Autophagy As A Treatment For Lysosomal Storage Diseases PCT PCT PCT/US2010/047730 Expired
NIA E-172-2009-0-PCT-02 Methods for Enhancing Genome Stability and Telomere Elongation in Embryonic Stem Cells PCT PCT PCT/US2010/047644 Expired
NCI E-132-2009-0-PCT-02 Oral Delivery Of A Vaccine To The Large Intestine To Induce Mucosal Immunity PCT PCT PCT/US2010/047338 Abandoned
NCI E-106-2006-3-US-03 T-cell Receptors And Related Materials and Methods of Use US DIV 12/870,941 8431690 Abandoned PDF
NCI E-201-2006-1-US-02 Compositions and Methods For Diagnosis and Treatment of Tumors US DIV 12/871,669 8247183 Abandoned PDF
NCATS E-252-2009-2-PCT-01 Inhibitors Of Human 15-Lipoxygenase-1 PCT PCT COMB PCT/US2010/047095 Abandoned
NICHD E-057-2008-0-KR-10 USE OF ULIPRISTAL ACETATE FOR TREATING UTERINE FIBROIDS KR National Stage 10-2010-7019181 Abandoned
NCI E-246-2003-1-AU-07 Non-Peptide Agonists and Antagonists of Adrenomedullin and Gastrin Releasing Peptide AU DIV 2010214693 Abandoned
NIAID E-283-2009-1-PCT-01 Compounds That Treat Malaria And Prevent Malaria Transmission PCT PCT COMB PCT/US2010/047019 Expired
NIAID E-283-2009-1-EP-04 Compounds That Treat Malaria And Prevent Malaria Transmission EP National Stage 10812670.7 Abandoned